MR perfusion characteristics of pseudoprogression in brain tumors treated with immunotherapy – a comparative study with chemo-radiation induced pseudoprogression and radiation necrosis
Journal of Neuro-Oncology · 2025
DOI: 10.1007/s11060-024-04910-0 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Neuro-Oncology, 2025. Verfasst von Hongyan Chen und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Brain Neoplasms, Immunotherapy, Radiation Injuries, Chemoradiotherapy. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: This work was supported by Scientists in the Bureau of Science and Technology of ShaoGuan.
Abstract (Originalsprache)
PURPOSE: Pseudoprogression is an atypical imaging pattern of response to immunotherapy in patients with brain tumors. MR perfusion studies in this field are limited. The purpose of our study is to compare the perfusion features between pseudoprogression lesions in malignant gliomas and brain metastases treated with immunotherapy (iPsP) and the pseudoprogression after chemo-radiation therapy and radiation necrosis after radiation treatment (ChR-PsP & RN). METHODS: We retrospectively reviewed 25 iPsP lesions in 16 brain tumor patients and 48 ChR-PsP & RN lesions in 35 patients. The cerebral blood volume (CBV) of MR dynamic susceptibility contrast (DSC) perfusion weighted imaging (PWI) was analyzed, and the mean and maximal values of the ratio of CBV (rCBVmean and rCBVmax) of iPsPs and ChR-PsP & RNs were calculated and compared between these two groups using the Mann-Whitney U test. A receiver operating characteristic curve analysis was conducted, and the optimal cutoff of perfusion parameters were determined using the area under the curve, sensitivity, and specificity. RESULTS: The medians of rCBVmean and rCBVmax in iPsP group were significantly higher (0.94 and 1.39 respectively) than ChR-PsP & RN group (0.67, p < 0.01 and 1.1, p = 0.01 respectively). The rCBVmean value of 0.69 can differentiate the iPsP from ChR-PsP & RN with the area under the curve of 0.71, sensitivity of 0.72, and specificity of 0.56. CONCLUSION: These findings may suggest immunotherapy-induced higher perfusion in the iPsP lesions compared to ChR-PsP & RN lesions in primary and metastatic brain tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
- Advanced Neuroimaging Laboratory, The Affiliated Yuebei People's Hospital of Shantou University Medical College, Shaoguan, Guangdong Province, China.
- Department of Radiology, The Affiliated Yuebei People's Hospital of Shantou University Medical College, Shaoguan, Guangdong Province, China.
- Department of Pathology, The Affiliated Yuebei People's Hospital of Shantou University Medical College, Shaoguan, Guangdong Province, China.
- Yanjing Medical College, Capital Medical University, Beijing, China.
- Interventional Radiotherapy Room, The Affiliated Yuebei People's Hospital of Shantou University Medical College, Shaoguan, Guangdong Province, China.
Förderung
- This work was supported by Scientists in the Bureau of Science and Technology of ShaoGuan
Zitieren
APA
Chen, H., Tan, G., Zhong, L., Hu, Y., Han, W., Huang, Y., Liang, Q., Szekeres, D., Jiang, H., Bharadwaj, R., Smith, S. M., Wang, H. Z., & Liu, X. (2025). MR perfusion characteristics of pseudoprogression in brain tumors treated with immunotherapy – a comparative study with chemo-radiation induced pseudoprogression and radiation necrosis. Journal of Neuro-Oncology. https://doi.org/10.1007/s11060-024-04910-0
Vancouver
Chen H, Tan G, Zhong L, Hu Y, Han W, Huang Y, et al. MR perfusion characteristics of pseudoprogression in brain tumors treated with immunotherapy – a comparative study with chemo-radiation induced pseudoprogression and radiation necrosis. Journal of Neuro-Oncology. 2025. doi:10.1007/s11060-024-04910-0
BibTeX
@article{Chen2025,
author = {Chen, Hongyan and Tan, Guirong and Zhong, Lijuan and Hu, Yichuan and Han, Wenjing and Huang, Yi and Liang, Qiong and Szekeres, Denes and Jiang, Haihui and Bharadwaj, Rajnish and Smith, Stephen M and Wang, Henry Z and Liu, Xiang},
title = {MR perfusion characteristics of pseudoprogression in brain tumors treated with immunotherapy – a comparative study with chemo-radiation induced pseudoprogression and radiation necrosis},
journal = {Journal of Neuro-Oncology},
year = {2025},
doi = {10.1007/s11060-024-04910-0}
}
EUVIMED